4basebio (4BB) Competitors GBX 1,110 -40.00 (-3.48%) As of 09:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock 4BB vs. SLN, PRTC, OXB, HZD, FARN, VRP, ARIX, AVCT, CIR, and BVXPShould you be buying 4basebio stock or one of its competitors? The main competitors of 4basebio include Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Avacta Group (AVCT), Circassia Group (CIR), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry. 4basebio vs. Silence Therapeutics PureTech Health Oxford Biomedica Horizon Discovery Group plc (HZD.L) Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) Arix Bioscience Avacta Group Circassia Group Bioventix 4basebio (LON:4BB) and Silence Therapeutics (LON:SLN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Does the MarketBeat Community favor 4BB or SLN? Silence Therapeutics received 202 more outperform votes than 4basebio when rated by MarketBeat users. However, 100.00% of users gave 4basebio an outperform vote while only 68.81% of users gave Silence Therapeutics an outperform vote. CompanyUnderperformOutperform4basebioOutperform Votes1100.00% Underperform VotesNo VotesSilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% Does the media prefer 4BB or SLN? In the previous week, 4basebio had 1 more articles in the media than Silence Therapeutics. MarketBeat recorded 1 mentions for 4basebio and 0 mentions for Silence Therapeutics. 4basebio's average media sentiment score of 0.00 equaled Silence Therapeutics'average media sentiment score. Company Overall Sentiment 4basebio Neutral Silence Therapeutics Neutral Is 4BB or SLN more profitable? Silence Therapeutics' return on equity of 0.00% beat 4basebio's return on equity.Company Net Margins Return on Equity Return on Assets 4basebioN/A -231.29% -54.30% Silence Therapeutics N/A N/A N/A Which has better earnings & valuation, 4BB or SLN? Silence Therapeutics has higher revenue and earnings than 4basebio. 4basebio is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio4basebio£311K473.68-£9.84M-£0.78-1,474.36Silence Therapeutics£11.35M0.00N/A-£48.60N/A Do insiders and institutionals hold more shares of 4BB or SLN? 2.0% of 4basebio shares are owned by institutional investors. 68.4% of 4basebio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts prefer 4BB or SLN? 4basebio presently has a consensus target price of GBX 1,600, indicating a potential upside of 39.13%. Given 4basebio's stronger consensus rating and higher possible upside, analysts clearly believe 4basebio is more favorable than Silence Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 4basebio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Silence Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Summary4basebio beats Silence Therapeutics on 8 of the 13 factors compared between the two stocks. Remove Ads Get 4basebio News Delivered to You Automatically Sign up to receive the latest news and ratings for 4BB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart 4BB vs. The Competition Export to ExcelMetric4basebioBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£147.32M£109.40M£5.63B£2.58BDividend YieldN/A3.78%5.33%4.82%P/E Ratio-1,474.363.1023.61141.64Price / Sales473.684,225.22384.78273,878.92Price / Cash16.0812.7538.1728.13Price / Book-28.0536.246.874.54Net Income-£9.84M-£91.48M£3.20B£5.81B7 Day Performance5.22%-2.40%-3.57%0.69%1 Month Performance-0.86%59.21%1.50%6.70%1 Year Performance19.79%82.96%9.09%30.45% 4basebio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)4BB4basebio1.7649 of 5 starsGBX 1,110-3.5%GBX 1,600+44.1%+19.8%£142.19M£311,000.00-1,423.08101High Trading VolumeSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health1.8468 of 5 starsGBX 127.60flatGBX 455+256.6%-33.8%£383.29M£521,320.79-5.23300Positive NewsOXBOxford Biomedica2.5241 of 5 starsGBX 305+1.2%GBX 560+83.6%+54.7%£324.22M£98.31M-2.27891HZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416FARNFaron Pharmaceuticals OyN/AGBX 191.69+0.9%N/A+47.5%£257.34MN/A-5.1334News CoverageVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919AVCTAvacta GroupN/AGBX 39.65+5.0%N/A-20.7%£150.62M£26.29M-5.10120CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,630-0.8%N/A-38.4%£137.72M£13.65M17.0112 Remove Ads Related Companies and Tools Related Companies Silence Therapeutics Competitors PureTech Health Competitors Oxford Biomedica Competitors Horizon Discovery Group plc (HZD.L) Competitors Faron Pharmaceuticals Oy Competitors Verona Pharma plc (VRP.L) Competitors Arix Bioscience Competitors Avacta Group Competitors Circassia Group Competitors Bioventix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:4BB) was last updated on 3/31/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.